Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study

Compared to clopidogrel, prasugrel has a lower incidence of ischemic events following percutaneous coronary intervention (PCI) because of an early reduction during the acute phase in P2Y12 reaction units (PRU). The objective of this study was to compare the antiplatelet effect and vascular endotheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuyama, Taiki, Sakuma, Masashi, Waku, Ryutaro, Hirose, Suguru, Kitahara, Keijiro, Naganuma, Jin, Yazawa, Hiroko, Toyoda, Shigeru, Abe, Shichiro, Nakajima, Toshiaki, Inoue, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940291/
https://www.ncbi.nlm.nih.gov/pubmed/33113567
http://dx.doi.org/10.1007/s00380-020-01714-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940291/
https://www.ncbi.nlm.nih.gov/pubmed/33113567
http://dx.doi.org/10.1007/s00380-020-01714-w

Ejemplares similares